ciprofloxacin has been researched along with Meningitis, Meningococcal, Serogroup A in 26 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Epidemics of meningococcal meningitis are common in the "African meningitis belt." | 2.84 | Ciprofloxacin for contacts of cases of meningococcal meningitis as an epidemic response: study protocol for a cluster-randomized trial. ( Alcoba, G; Ciglenecki, I; Coldiron, ME; Djibo, A; Grais, RF; Hitchings, M; Langendorf, C; Page, AL, 2017) |
| "Neonates are the most at risk of acute bacterial meningitis." | 1.39 | Bacterial isolates from cerebrospinal fluid of children with suspected acute meningitis in a Nigerian tertiary hospital. ( Egesie, JO; Kashibu, E; Nwadioha, SI; Nwokedi, EO; Onwuezube, I, 2013) |
| "Three cases of recrudescence and relapse of Neisseria meningitidis group B meningitis and septicaemia are reported." | 1.29 | Recrudescence and relapse of meningococcal meningitis and septicaemia. ( Nielsen, PE; Thelle, T; Tvede, M, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (11.54) | 18.7374 |
| 1990's | 4 (15.38) | 18.2507 |
| 2000's | 6 (23.08) | 29.6817 |
| 2010's | 12 (46.15) | 24.3611 |
| 2020's | 1 (3.85) | 2.80 |
| Authors | Studies |
|---|---|
| Hedberg, ST | 1 |
| Fredlund, H | 1 |
| Nicolas, P | 1 |
| Caugant, DA | 1 |
| Olcén, P | 1 |
| Unemo, M | 1 |
| Willerton, L | 1 |
| Lucidarme, J | 1 |
| Walker, A | 1 |
| Lekshmi, A | 1 |
| Clark, SA | 1 |
| Walsh, L | 1 |
| Bai, X | 1 |
| Lee-Jones, L | 1 |
| Borrow, R | 1 |
| Rude, JM | 1 |
| Kortimai, L | 1 |
| Mosoka, F | 1 |
| April, B | 1 |
| Nuha, M | 1 |
| Katawera, V | 1 |
| Nagbe, T | 1 |
| Tamba, A | 1 |
| Desmound, W | 1 |
| Mulbah, R | 1 |
| Pierre, F | 1 |
| Onuche, EM | 1 |
| Chukwudi, JO | 1 |
| Talisuna, A | 1 |
| Yahaya, AA | 1 |
| Rajatonirina, S | 1 |
| Nyenswah, T | 1 |
| Dahn, B | 1 |
| Gasasira, A | 1 |
| Fall, IS | 1 |
| Coldiron, ME | 2 |
| Alcoba, G | 2 |
| Ciglenecki, I | 2 |
| Hitchings, M | 1 |
| Djibo, A | 1 |
| Page, AL | 2 |
| Langendorf, C | 2 |
| Grais, RF | 2 |
| Seib, KL | 1 |
| Jen, FE | 1 |
| Scott, AL | 1 |
| Tan, A | 1 |
| Jennings, MP | 1 |
| Lee, H | 1 |
| Seo, Y | 1 |
| Kim, KH | 1 |
| Lee, K | 1 |
| Choe, KW | 1 |
| Klugman, KP | 1 |
| Izadnegahdar, R | 1 |
| Assao, B | 1 |
| Hitchings, MDT | 1 |
| Mambula, C | 1 |
| Adehossi, E | 1 |
| Sidikou, F | 1 |
| Tassiou, EI | 1 |
| De Lastours, V | 1 |
| Sorhouet-Pereira, C | 1 |
| Efron, A | 1 |
| Gagetti, P | 1 |
| Faccone, D | 1 |
| Regueira, M | 1 |
| Corso, A | 1 |
| Gabastou, JM | 1 |
| Ibarz-Pavón, AB | 1 |
| Nwadioha, SI | 1 |
| Nwokedi, EO | 1 |
| Onwuezube, I | 1 |
| Egesie, JO | 1 |
| Kashibu, E | 1 |
| Biswas, HH | 1 |
| Han, GS | 1 |
| Wendorf, K | 1 |
| Winter, K | 1 |
| Zipprich, J | 1 |
| Perti, T | 1 |
| Martinez, L | 1 |
| Arellano, A | 1 |
| Kyle, JL | 1 |
| Zhang, P | 1 |
| Harriman, K | 1 |
| McMahan, DA | 1 |
| Pitcher, ED | 1 |
| Waldron, MR | 1 |
| Billman, AS | 1 |
| Richards, SM | 1 |
| Pontones, PR | 1 |
| Duwve, JM | 1 |
| Lapadula, G | 1 |
| Viganò, F | 1 |
| Fortuna, P | 1 |
| Dolara, A | 1 |
| Bramati, S | 1 |
| Soria, A | 1 |
| Foresti, S | 1 |
| Gori, A | 1 |
| Gorla, MC | 1 |
| de Paiva, MV | 1 |
| Salgueiro, VC | 1 |
| Lemos, AP | 1 |
| Brandão, AP | 1 |
| Vázquez, JA | 2 |
| Brandileone, MC | 1 |
| Alcalá, B | 1 |
| Salcedo, C | 1 |
| de la Fuente, L | 1 |
| Arreaza, L | 1 |
| Uría, MJ | 1 |
| Abad, R | 1 |
| Enríquez, R | 1 |
| Motgé, M | 1 |
| de Batlle, J | 1 |
| Faye, A | 1 |
| Mariani-Kurkjian, P | 1 |
| Taha, MK | 1 |
| Louzeau, C | 1 |
| Bingen, E | 1 |
| Bourrillon, A | 1 |
| Prasad, K | 1 |
| Karlupia, N | 1 |
| Nielsen, PE | 1 |
| Thelle, T | 1 |
| Tvede, M | 1 |
| Martin, MJ | 1 |
| Hutchinson, NA | 1 |
| Eltringham, IJ | 1 |
| Lee, PY | 1 |
| Birthistle, K | 1 |
| Tsakris, A | 1 |
| Trakatelli, C | 1 |
| Souliou, E | 1 |
| Sofianou, D | 1 |
| Ntoutsou, K | 1 |
| Antoniadis, A | 1 |
| Jones, DM | 1 |
| Gaunt, PN | 2 |
| Lambert, BE | 2 |
| Dworzack, DL | 1 |
| Sanders, CC | 1 |
| Horowitz, EA | 1 |
| Allais, JM | 1 |
| Sookpranee, M | 1 |
| Sanders, WE | 1 |
| Ferraro, FM | 1 |
| Evans, CW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Cluster-randomized Trial to Evaluate the Impact of Ciprofloxacin for Contacts of Cases of Meningococcal Meningitis as an Epidemic Response[NCT02724046] | Phase 4 | 300 participants (Actual) | Interventional | 2017-04-22 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for ciprofloxacin and Meningitis, Meningococcal, Serogroup A
| Article | Year |
|---|---|
Prevention of bacterial meningitis: an overview of Cochrane systematic reviews.
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Ciprofloxacin; Female; Humans; Male; Meningitis, Meni | 2007 |
3 trials available for ciprofloxacin and Meningitis, Meningococcal, Serogroup A
| Article | Year |
|---|---|
Ciprofloxacin for contacts of cases of meningococcal meningitis as an epidemic response: study protocol for a cluster-randomized trial.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clinical Protocols; Contact Tracing; Drug Resistance, Bacteria | 2017 |
Single-dose oral ciprofloxacin prophylaxis as a response to a meningococcal meningitis epidemic in the African meningitis belt: A 3-arm, open-label, cluster-randomized trial.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Child; Child | 2018 |
Evaluation of single-dose ciprofloxacin in the eradication of Neisseria meningitidis from nasopharyngeal carriers.
Topics: Carrier State; Ciprofloxacin; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation | 1988 |
22 other studies available for ciprofloxacin and Meningitis, Meningococcal, Serogroup A
| Article | Year |
|---|---|
Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives.
Topics: Africa; Genotype; Humans; Meningitis, Meningococcal; Microbial Sensitivity Tests; Neisseria meningit | 2009 |
Antibiotic resistance among invasive Neisseria meningitidis isolates in England, Wales and Northern Ireland (2010/11 to 2018/19).
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Microbial; England; Humans; Meni | 2021 |
Rapid response to meningococcal disease cluster in Foya district, Lofa County, Liberia January to February 2018.
Topics: Adolescent; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Diseas | 2019 |
Phase variation of DNA methyltransferases and the regulation of virulence and immune evasion in the pathogenic Neisseria.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Ceftazidime; Ciprofloxacin; DNA Methylatio | 2017 |
Continuing risk of meningitis due to Neisseria meningitidis serogroup C in Africa: revised recommendations from a WHO expert consultation.
Topics: Advisory Committees; Africa; Anti-Bacterial Agents; Benin; Burkina Faso; Ciprofloxacin; Epidemics; H | 2017 |
Prevalence and serogroup changes of Neisseria meningitidis in South Korea, 2010-2016.
Topics: Adolescent; Adult; Aged; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacte | 2018 |
Antibiotic prophylaxis-Preventing severe infections and saving lives in poor countries with very high mortality risk.
Topics: Africa South of the Sahara; Antibiotic Prophylaxis; Ciprofloxacin; Humans; Meningitis, Meningococcal | 2018 |
Phenotypic and genotypic characteristics of Neisseria meningitidis disease-causing strains in Argentina, 2010.
Topics: Anti-Infective Agents; Argentina; Ciprofloxacin; Drug Resistance, Bacterial; Genotype; Humans; Menin | 2013 |
Bacterial isolates from cerebrospinal fluid of children with suspected acute meningitis in a Nigerian tertiary hospital.
Topics: Adolescent; Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cerebrospinal Fluid; Child; Child, Presc | 2013 |
Notes from the Field: Outbreak of Serogroup B Meningococcal Disease at a University - California, 2016.
Topics: Adolescent; California; Ciprofloxacin; Contact Tracing; Disease Outbreaks; Humans; Meningitis, Menin | 2016 |
Notes from the Field: Expanded Chemoprophylaxis Offered in Response to a Case of Meningococcal Meningitis in an Elementary School - Indiana, 2015.
Topics: Adult; Child; Ciprofloxacin; Contact Tracing; Female; Humans; Indiana; Male; Meningitis, Meningococc | 2016 |
Imported ciprofloxacin-resistant Neisseria meningitidis.
Topics: Adult; Ciprofloxacin; Communicable Diseases, Emerging; Contact Tracing; Drug Resistance, Bacterial; | 2009 |
Antimicrobial susceptibility of Neisseria meningitidis strains isolated from meningitis cases in Brazil from 2006 to 2008.
Topics: Adolescent; Adult; Anti-Bacterial Agents; beta-Lactams; Brazil; Child; Child, Preschool; Chloramphen | 2011 |
Neisseria meningitidis showing decreased susceptibility to ciprofloxacin: first report in Spain.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Infant; Male; Meningitis, | 2004 |
[Clinical aspects and outcome of meningococcal disease due to Neisseria meningitidis of serogroup W135 in 5 children].
Topics: Anti-Bacterial Agents; Arthritis, Infectious; Cefotaxime; Child; Child, Preschool; Ciprofloxacin; Fe | 2005 |
Recrudescence and relapse of meningococcal meningitis and septicaemia.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacteremia; Child, Preschool; Chloramphenicol; Ciproflo | 1995 |
Secondary prevention of meningococcal disease. Ceftriaxone or ciprofloxacin should be considered as first line prophylaxis.
Topics: Ceftriaxone; Ciprofloxacin; Humans; Meningitis, Meningococcal; Meningococcal Infections | 1996 |
Advice for travelers.
Topics: Anti-Infective Agents; Antidiarrheals; Bacterial Vaccines; Cholera; Ciprofloxacin; Diarrhea; Diphthe | 1998 |
Failures of rifampicin and ciprofloxacin to eradicate a susceptible meningococcal isolate from a close contact of a fatal case.
Topics: Adolescent; Anti-Infective Agents; Antibiotic Prophylaxis; Antibiotics, Antitubercular; Ciprofloxaci | 2001 |
Chemoprophylaxis of meningitis.
Topics: Ciprofloxacin; Humans; Meningitis, Haemophilus; Meningitis, Meningococcal; Rifampin; Vaccination | 1991 |
Single dose ciprofloxacin for the eradication of pharyngeal carriage of Neisseria meningitidis.
Topics: Carrier State; Ciprofloxacin; Half-Life; Humans; Meningitis, Meningococcal; Meningococcal Infections | 1988 |
A description of the outbreak of meningitis in HMS Raleigh in February 1987.
Topics: Adolescent; Ciprofloxacin; Disease Outbreaks; Drug Resistance, Microbial; Humans; Male; Meningitis, | 1988 |